![]() |
市場調查報告書
商品編碼
2061381
自動化縫合器材市場機會、成長要素、產業趨勢分析及2026-2035年預測。Automated Suturing Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026 - 2035 |
||||||
預計到 2025 年,全球自動縫合設備市場價值將達到 6.284 億美元,年複合成長率為 6.7%,到 2035 年將達到 12 億美元。

全球外科手術數量的增加、創傷和事故相關病例的上升以及機器人輔助手術技術的不斷進步,共同推動了市場擴張。慢性疾病負擔的加重、全球人口老化以及擇期手術的持續成長,都導致了手術量的激增,並強化了對高效傷口縫合解決方案的需求。醫療專業人員正擴大採用自動化縫合設備來簡化手術流程、縮短手術時間、提高手術精度並減輕外科醫生的疲勞。這些設備能夠提供一致的縫合效果,從而提高患者康復率並降低併發症風險。在整形外科、心血管外科和胃腸外科等手術量較大的專科領域,自動化縫合設備的應用尤其顯著。同時,與機器人手術平台的整合正在提高複雜手術的精準度、可操作性和可視性,支持微創手術,並進一步加速其在現代醫療保健系統中的市場滲透。
| 市場範圍 | |
|---|---|
| 開始年份 | 2025 |
| 預測期 | 2026-2035 |
| 初始市場規模 | 6.284億美元 |
| 預測金額 | 12億美元 |
| 複合年成長率 | 6.7% |
到2025年,一次性醫療器材市場佔有率將達到64.5%,這主要得益於市場對一次性手術器械的強勁需求,這些器械能夠最大限度地降低感染風險,並符合嚴格的臨床衛生標準。一次性自動縫合器械的需求持續成長,因為它們易於使用、無需重複處理,並且能夠適應快節奏的手術環境。這些器械降低了交叉感染的可能性,並有助於更安全的手術操作,尤其是在患者周轉率高的醫療機構中。它們的便利性和可靠性正在推動醫療系統在提高效率和安全性方面進行廣泛的臨床應用。
到2025年,胃腸外科領域將佔據32.6%的市場。自動縫合器廣泛應用於胃腸外科手術,尤其是在微創腹腔鏡手術中,精準度、速度和可靠的組織縫合至關重要。透過這些設備,外科醫師可以在有限的解剖空間內進行精準縫合,同時縮短手術時間,改善術後恢復效果。它們還有助於降低滲漏和傷口縫合不當等併發症的風險。胃腸道疾病發生率的不斷上升,以及先進外科技術的廣泛應用,持續推動該領域對這些設備的持續需求。
預計2025年,北美自動縫合器材市佔率將達到33.4%。該地區受益於高度發展的醫療基礎設施、機器人輔助手術系統的早期應用以及對微創手術的強烈偏好。慢性病和人口老化導致的大量手術進一步支撐了自動縫合技術的穩定需求。領先的醫療設備製造商、完善的醫保報銷機制以及對臨床培訓和手術創新持續投入,都進一步推動了該地區的市場成長。新一代手術平台的廣泛應用也提高了醫院和手術中心的採用率。
The Global Automated Suturing Devices Market was valued at USD 628.4 million in 2025 and is estimated to grow at a CAGR of 6.7% to reach USD 1.2 billion by 2035.

Market expansion is driven by the rising number of surgical interventions globally, increasing incidence of trauma and accident-related cases, and continuous advancements in robotic-assisted surgical technologies. The growing burden of chronic illnesses, an aging global population, and a steady rise in elective procedures are collectively pushing surgical volumes higher, strengthening demand for efficient wound closure solutions. Automated suturing devices are increasingly being adopted by healthcare providers to streamline surgical workflows, reduce operating time, and enhance procedural accuracy while minimizing surgeon fatigue. Their ability to deliver consistent suturing outcomes is improving patient recovery rates and reducing complication risks. Adoption is especially strong in high-volume specialties such as orthopedic, cardiovascular, and gastrointestinal surgeries. In parallel, integration with robotic surgical platforms is enhancing precision, dexterity, and visualization during complex procedures, supporting minimally invasive approaches and further accelerating market uptake across modern healthcare systems.
| Market Scope | |
|---|---|
| Start Year | 2025 |
| Forecast Year | 2026-2035 |
| Start Value | $628.4 Million |
| Forecast Value | $1.2 Billion |
| CAGR | 6.7% |
The disposable segment accounted for 64.5% share in 2025, supported by a strong preference for single-use surgical tools that help minimize infection risks and comply with strict clinical hygiene standards. Demand for disposable automated suturing devices continues to rise due to their operational simplicity, elimination of reprocessing requirements, and suitability for fast-paced surgical environments. These devices reduce the possibility of cross-contamination and support safer surgical practices, particularly in facilities handling high patient turnover. Their convenience and reliability are reinforcing widespread clinical adoption across healthcare systems focused on improving efficiency and safety outcomes.
The gastrointestinal surgery segment captured a share of 32.6% in 2025. Automated suturing devices are widely utilized in gastrointestinal procedures where precision, speed, and secure tissue closure are critical, particularly in minimally invasive laparoscopic interventions. Their use enables surgeons to perform accurate suturing in confined anatomical spaces while reducing procedure time and improving postoperative recovery outcomes. They also help lower the risk of complications such as leakage and improper wound closure. The increasing incidence of gastrointestinal conditions, along with growing adoption of advanced surgical techniques, continues to drive sustained demand for these devices in this segment.
North America Automated Suturing Devices Market held a 33.4% share in 2025. The region benefits from a highly developed healthcare infrastructure, early adoption of robotic-assisted surgical systems, and a strong preference for minimally invasive procedures. A high surgical caseload driven by chronic diseases and an aging population further supports consistent demand for automated suturing technologies. The presence of leading medical device manufacturers, advanced reimbursement frameworks, and ongoing investments in clinical training and surgical innovation continue to strengthen regional market growth. Widespread integration of next-generation surgical platforms is also enhancing adoption rates across hospitals and surgical centers.
Major companies operating in the Global Automated Suturing Devices Market include Boston Scientific, Johnson & Johnson MedTech, Medtronic, Anchora Medical, ErgoSuture, LSI Solutions, Mellon Medical, and Suturion. Companies in the automated suturing devices market are focusing on continuous product innovation, through integration with robotic-assisted surgical systems to improve precision and procedural control. Many players are expanding their product portfolios with advanced disposable and reusable suturing solutions tailored for different surgical specialties. Strategic collaborations with hospitals, research institutions, and surgical centers are being used to accelerate clinical adoption and expand application areas. Firms are also investing in surgeon training programs to improve device proficiency and adoption rates. Geographic expansion into emerging healthcare markets is strengthening revenue streams.